Heather Howard Email & Phone Number

Charleston, South Carolina Metropolitan Area

Serve as the primary account lead within national and regional accounts, including hospital systems, IDNs, criminal justice systems, and federal health systems to gain formulary additions, identify procurement strategies, and provide value-based solutions to develop new business opportunities and drive results- function of the role is primarily dedicated to SUBLOCADE®, for treatment of opioid use disorder; secondary product, PERSERIS®, for treatment of schizophrenia.

Responsible for pre-launch activity aspects of market penetration, development, and strategic planning within targeted Key Accounts. Launch of disease state awareness campaign to gain meaningful outcomes for patients by influencing nephrology HCPs for early intervention of Metabolic Acidosis to prevent CKD. Utilize market research tools to coordinate activities through analyzing and optimizing industry trends, competitive data, and priority accounts to achieve and exceed assigned quarterly and… Show more Responsible for pre-launch activity aspects of market penetration, development, and strategic planning within targeted Key Accounts. Launch of disease state awareness campaign to gain meaningful outcomes for patients by influencing nephrology HCPs for early intervention of Metabolic Acidosis to prevent CKD. Utilize market research tools to coordinate activities through analyzing and optimizing industry trends, competitive data, and priority accounts to achieve and exceed assigned quarterly and annual KPIs. *CLR received Q3 and commercialization ended Q4. Show less

Responsible for marketplace education and KOL engagement to establish treatment pathway for NATPARA. Contributed to the standard of care change by partnering with health-systems, large group practices, specialists (endocrinologists, nephrologists, internists, ENTs, hospitalists, nurses, pharmacists, and C&D suite hospital leadership) who focus on the treatment and outcomes of chronic rare disease patients suffering from hypoparathyroidism, make the medication channel readily available to… Show more Responsible for marketplace education and KOL engagement to establish treatment pathway for NATPARA. Contributed to the standard of care change by partnering with health-systems, large group practices, specialists (endocrinologists, nephrologists, internists, ENTs, hospitalists, nurses, pharmacists, and C&D suite hospital leadership) who focus on the treatment and outcomes of chronic rare disease patients suffering from hypoparathyroidism, make the medication channel readily available to patients. Show less

Launch specialist for OTIPRIO, engaged ENT thought leaders through education of new technology and outcome-focused goals for patients and caregivers to compel KOLs to champion the process of making product available within IDNs, as well as privately held surgical centers; supported claims analytics and reimbursement guidance for miscellaneous J code. Identified and developed thought leaders in a highly specialized marketplace to advocate for formulary additions within health-systems and… Show more Launch specialist for OTIPRIO, engaged ENT thought leaders through education of new technology and outcome-focused goals for patients and caregivers to compel KOLs to champion the process of making product available within IDNs, as well as privately held surgical centers; supported claims analytics and reimbursement guidance for miscellaneous J code. Identified and developed thought leaders in a highly specialized marketplace to advocate for formulary additions within health-systems and established access through specialty pharmacy program to achieve pull-through activations. Show less

Responsible for comprehensive KOL and hospital account management for national and regional accounts- focused efforts in the topical hemostatic device market for THROMBIN-JMI and in pain management for DYLOJECT. Applied a consultative selling approach to achieve hospital formulary additions, automation, and system-wide initiatives to yield higher patient safety outcomes and product value propositions- attention dedicated to end users, value analysis team (SVAT), P&T committee, CMOs… Show more Responsible for comprehensive KOL and hospital account management for national and regional accounts- focused efforts in the topical hemostatic device market for THROMBIN-JMI and in pain management for DYLOJECT. Applied a consultative selling approach to achieve hospital formulary additions, automation, and system-wide initiatives to yield higher patient safety outcomes and product value propositions- attention dedicated to end users, value analysis team (SVAT), P&T committee, CMOs, hospitalists, and C & D-suite hospital administration. Provided continuous total account management through clinical in-services, miscellaneous J-code support, and usage based on HEOR data within IDNs, including ACO facilities. Show less

Specialized in key account selling of advanced medical devices for plastic and reconstructive trauma procedures, small fragment orthopedic systems, and a complimenting line of Orthopedic Power equipment with disposables. Responsible for sales team management, daily business operations, invoicing, inventory efficiency, contracting, forecasting, prospect targeting, and sales quota attainment.

Specialized in key account selling of advanced medical devices for plastic and reconstructive trauma procedures, small fragment orthopedic systems, and a complimenting line of Orthopedic Power equipment with disposables. Responsible for sales team management, daily business operations, invoicing, inventory efficiency, contracting, forecasting, prospect targeting, and sales quota attainment.